Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT ... Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -15.99 | -14.54561994 | 109.93 | 110.55 | 93.94 | 1579254 | 100.74665807 | CS |
| 4 | -11.93 | -11.2685368849 | 105.87 | 118.25 | 93.94 | 1029087 | 107.37741518 | CS |
| 12 | -3.45 | -3.54245815792 | 97.39 | 118.25 | 85.91 | 815761 | 100.01601098 | CS |
| 26 | 0.83 | 0.891418752014 | 93.11 | 118.25 | 80.675 | 696726 | 95.27970588 | CS |
| 52 | 21.69 | 30.0207612457 | 72.25 | 121.9 | 72.24 | 719203 | 96.95786741 | CS |
| 156 | 11.59 | 14.0740740741 | 82.35 | 121.9 | 37.82 | 712191 | 71.47460084 | CS |
| 260 | 30.47 | 48.006932409 | 63.47 | 125.61 | 37.82 | 627902 | 75.94155497 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
